Concepts (306)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 29 | 2025 | 700 | 3.620 |
Why?
|
| Diabetes Mellitus | 7 | 2024 | 439 | 1.990 |
Why?
|
| Hypertension | 10 | 2024 | 1024 | 1.760 |
Why?
|
| Low Back Pain | 7 | 2022 | 47 | 1.180 |
Why?
|
| United States | 34 | 2025 | 4267 | 1.150 |
Why?
|
| Medicare | 3 | 2025 | 217 | 1.130 |
Why?
|
| Automobile Driving | 5 | 2023 | 26 | 1.110 |
Why?
|
| Humans | 89 | 2025 | 34474 | 1.050 |
Why?
|
| Rural Population | 3 | 2024 | 297 | 1.000 |
Why?
|
| Risk Factors | 26 | 2025 | 4136 | 0.970 |
Why?
|
| Accidents, Traffic | 6 | 2023 | 196 | 0.930 |
Why?
|
| Models, Statistical | 3 | 2023 | 193 | 0.900 |
Why?
|
| Female | 58 | 2025 | 21490 | 0.880 |
Why?
|
| Ambulatory Care | 1 | 2025 | 113 | 0.840 |
Why?
|
| Body Mass Index | 5 | 2025 | 953 | 0.830 |
Why?
|
| Aged | 32 | 2025 | 10998 | 0.810 |
Why?
|
| Licensure | 4 | 2023 | 7 | 0.810 |
Why?
|
| Urban Population | 1 | 2024 | 97 | 0.810 |
Why?
|
| Male | 48 | 2025 | 20697 | 0.800 |
Why?
|
| Health Status Disparities | 6 | 2023 | 138 | 0.780 |
Why?
|
| Obesity | 3 | 2025 | 1244 | 0.680 |
Why?
|
| Middle Aged | 32 | 2025 | 12703 | 0.620 |
Why?
|
| Adult | 32 | 2025 | 10015 | 0.620 |
Why?
|
| Cohort Studies | 14 | 2025 | 1910 | 0.580 |
Why?
|
| Incidence | 14 | 2024 | 1288 | 0.570 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2019 | 124 | 0.540 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2024 | 1523 | 0.520 |
Why?
|
| Social Class | 7 | 2023 | 94 | 0.520 |
Why?
|
| Longitudinal Studies | 14 | 2025 | 801 | 0.510 |
Why?
|
| Substance-Related Disorders | 4 | 2020 | 140 | 0.480 |
Why?
|
| Dental Hygienists | 1 | 2014 | 1 | 0.440 |
Why?
|
| Epidemiologic Research Design | 1 | 2014 | 5 | 0.440 |
Why?
|
| Poisson Distribution | 3 | 2023 | 19 | 0.440 |
Why?
|
| Unsafe Sex | 1 | 2014 | 23 | 0.430 |
Why?
|
| C-Reactive Protein | 3 | 2021 | 248 | 0.430 |
Why?
|
| Wounds and Injuries | 1 | 2016 | 242 | 0.410 |
Why?
|
| Public Health | 1 | 2014 | 94 | 0.400 |
Why?
|
| Cardiovascular Diseases | 5 | 2022 | 1209 | 0.400 |
Why?
|
| Aged, 80 and over | 8 | 2025 | 4150 | 0.400 |
Why?
|
| Caregivers | 2 | 2025 | 116 | 0.390 |
Why?
|
| Students | 1 | 2014 | 178 | 0.390 |
Why?
|
| Computer Simulation | 5 | 2023 | 250 | 0.390 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 193 | 0.390 |
Why?
|
| Protein Precursors | 2 | 2024 | 27 | 0.390 |
Why?
|
| Cross-Sectional Studies | 7 | 2024 | 1607 | 0.350 |
Why?
|
| Child Restraint Systems | 2 | 2021 | 3 | 0.330 |
Why?
|
| Analgesics, Opioid | 3 | 2020 | 265 | 0.330 |
Why?
|
| Coronary Disease | 3 | 2022 | 239 | 0.320 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2024 | 302 | 0.310 |
Why?
|
| Dental Caries | 3 | 2019 | 22 | 0.310 |
Why?
|
| Prevalence | 5 | 2024 | 1034 | 0.300 |
Why?
|
| HIV Infections | 1 | 2014 | 429 | 0.300 |
Why?
|
| Antihypertensive Agents | 2 | 2024 | 378 | 0.290 |
Why?
|
| Fertility | 3 | 2013 | 32 | 0.280 |
Why?
|
| Residence Characteristics | 4 | 2022 | 188 | 0.280 |
Why?
|
| DMF Index | 3 | 2019 | 6 | 0.280 |
Why?
|
| Exercise | 5 | 2024 | 700 | 0.270 |
Why?
|
| Leisure Activities | 2 | 2024 | 16 | 0.270 |
Why?
|
| Prospective Studies | 9 | 2024 | 2461 | 0.250 |
Why?
|
| Child | 10 | 2024 | 2613 | 0.240 |
Why?
|
| Socioeconomic Factors | 6 | 2023 | 446 | 0.240 |
Why?
|
| Enkephalins | 2 | 2024 | 11 | 0.230 |
Why?
|
| Comorbidity | 2 | 2025 | 596 | 0.230 |
Why?
|
| Cognition | 3 | 2024 | 576 | 0.230 |
Why?
|
| Work Schedule Tolerance | 1 | 2024 | 11 | 0.220 |
Why?
|
| Regression Analysis | 2 | 2016 | 310 | 0.220 |
Why?
|
| Diet | 6 | 2023 | 418 | 0.220 |
Why?
|
| Mental Health | 2 | 2023 | 126 | 0.220 |
Why?
|
| Circadian Rhythm | 1 | 2024 | 50 | 0.220 |
Why?
|
| Severity of Illness Index | 2 | 2025 | 922 | 0.210 |
Why?
|
| Leptin | 1 | 2024 | 75 | 0.210 |
Why?
|
| Depression | 3 | 2025 | 458 | 0.210 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2024 | 28 | 0.210 |
Why?
|
| Patient Discharge | 1 | 2025 | 214 | 0.200 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2024 | 60 | 0.200 |
Why?
|
| Cognition Disorders | 2 | 2024 | 390 | 0.200 |
Why?
|
| Independent Living | 1 | 2024 | 95 | 0.200 |
Why?
|
| Ovulation Detection | 2 | 2013 | 2 | 0.200 |
Why?
|
| Survivors | 1 | 2025 | 177 | 0.200 |
Why?
|
| Sleep | 2 | 2021 | 90 | 0.190 |
Why?
|
| Pregnancy | 8 | 2021 | 1069 | 0.190 |
Why?
|
| Health Behavior | 2 | 2021 | 246 | 0.190 |
Why?
|
| Blood Glucose | 2 | 2025 | 529 | 0.190 |
Why?
|
| Activities of Daily Living | 1 | 2024 | 267 | 0.190 |
Why?
|
| Hypoglycemic Agents | 1 | 2024 | 200 | 0.190 |
Why?
|
| Motor Activity | 1 | 2024 | 356 | 0.180 |
Why?
|
| Neuropeptides | 1 | 2022 | 23 | 0.180 |
Why?
|
| Air Pollution | 1 | 2021 | 17 | 0.180 |
Why?
|
| Air Pollutants | 1 | 2021 | 27 | 0.180 |
Why?
|
| Peptide Fragments | 2 | 2022 | 429 | 0.180 |
Why?
|
| Quality of Life | 2 | 2025 | 1032 | 0.170 |
Why?
|
| Retrospective Studies | 4 | 2024 | 3812 | 0.170 |
Why?
|
| Sex Factors | 5 | 2021 | 707 | 0.170 |
Why?
|
| Adolescent | 6 | 2023 | 3799 | 0.170 |
Why?
|
| Firearms | 1 | 2021 | 8 | 0.170 |
Why?
|
| Seat Belts | 1 | 2021 | 17 | 0.170 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2021 | 89 | 0.170 |
Why?
|
| Geography | 4 | 2021 | 36 | 0.170 |
Why?
|
| Aggression | 1 | 2020 | 31 | 0.160 |
Why?
|
| Soccer | 1 | 2020 | 19 | 0.160 |
Why?
|
| Sports | 1 | 2021 | 42 | 0.160 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2020 | 38 | 0.160 |
Why?
|
| Risk Assessment | 6 | 2024 | 1506 | 0.150 |
Why?
|
| Sex Characteristics | 1 | 2020 | 182 | 0.150 |
Why?
|
| Pregnancy Complications | 2 | 2017 | 115 | 0.150 |
Why?
|
| Area Under Curve | 1 | 2019 | 98 | 0.150 |
Why?
|
| Selection Bias | 1 | 2019 | 13 | 0.150 |
Why?
|
| Young Adult | 5 | 2024 | 2825 | 0.150 |
Why?
|
| Athletic Injuries | 1 | 2020 | 97 | 0.150 |
Why?
|
| Algorithms | 1 | 2022 | 560 | 0.140 |
Why?
|
| Dyslipidemias | 1 | 2019 | 61 | 0.140 |
Why?
|
| Cholesterol, HDL | 1 | 2019 | 194 | 0.140 |
Why?
|
| Case-Control Studies | 4 | 2023 | 924 | 0.140 |
Why?
|
| Pain Measurement | 4 | 2022 | 385 | 0.140 |
Why?
|
| Substance Abuse Detection | 1 | 2017 | 10 | 0.140 |
Why?
|
| Odds Ratio | 1 | 2019 | 480 | 0.130 |
Why?
|
| Cholesterol, LDL | 1 | 2018 | 185 | 0.130 |
Why?
|
| Narcotics | 1 | 2017 | 32 | 0.130 |
Why?
|
| Carotid Artery Diseases | 1 | 2018 | 129 | 0.130 |
Why?
|
| Dietary Sucrose | 1 | 2017 | 11 | 0.130 |
Why?
|
| Risk Reduction Behavior | 1 | 2017 | 129 | 0.130 |
Why?
|
| Cocaine | 2 | 2017 | 355 | 0.130 |
Why?
|
| Heart Failure | 1 | 2024 | 780 | 0.130 |
Why?
|
| Bicycling | 1 | 2016 | 14 | 0.120 |
Why?
|
| Placenta Previa | 1 | 2016 | 2 | 0.120 |
Why?
|
| Time Factors | 5 | 2024 | 2352 | 0.120 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2016 | 13 | 0.120 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 2016 | 1 | 0.120 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2016 | 13 | 0.120 |
Why?
|
| Binomial Distribution | 1 | 2015 | 2 | 0.120 |
Why?
|
| Delivery, Obstetric | 1 | 2016 | 60 | 0.120 |
Why?
|
| Accidents | 1 | 2015 | 5 | 0.120 |
Why?
|
| Benzodiazepines | 1 | 2015 | 10 | 0.120 |
Why?
|
| Premature Birth | 1 | 2016 | 75 | 0.110 |
Why?
|
| Dentin | 1 | 2014 | 1 | 0.110 |
Why?
|
| Calcium Hydroxide | 1 | 2014 | 2 | 0.110 |
Why?
|
| Silicates | 1 | 2014 | 3 | 0.110 |
Why?
|
| Aluminum Compounds | 1 | 2014 | 4 | 0.110 |
Why?
|
| Root Canal Filling Materials | 1 | 2014 | 3 | 0.110 |
Why?
|
| Calcium Compounds | 1 | 2014 | 9 | 0.110 |
Why?
|
| Dental Care for Aged | 1 | 2014 | 6 | 0.110 |
Why?
|
| Stereotyping | 1 | 2014 | 10 | 0.110 |
Why?
|
| Homes for the Aged | 1 | 2014 | 13 | 0.110 |
Why?
|
| Lead | 1 | 2014 | 6 | 0.110 |
Why?
|
| Oxides | 1 | 2014 | 18 | 0.110 |
Why?
|
| Harm Reduction | 1 | 2014 | 16 | 0.110 |
Why?
|
| Nursing Homes | 1 | 2014 | 33 | 0.110 |
Why?
|
| Likelihood Functions | 1 | 2014 | 52 | 0.110 |
Why?
|
| Opioid-Related Disorders | 1 | 2015 | 69 | 0.110 |
Why?
|
| Inflammation | 3 | 2022 | 557 | 0.110 |
Why?
|
| Reproducibility of Results | 3 | 2025 | 819 | 0.100 |
Why?
|
| Cervix Mucus | 1 | 2013 | 1 | 0.100 |
Why?
|
| Parents | 3 | 2023 | 159 | 0.100 |
Why?
|
| West Virginia | 3 | 2020 | 16 | 0.100 |
Why?
|
| Follicle Stimulating Hormone, Human | 1 | 2012 | 1 | 0.100 |
Why?
|
| Lubricants | 1 | 2012 | 2 | 0.090 |
Why?
|
| Proportional Hazards Models | 3 | 2022 | 803 | 0.090 |
Why?
|
| Albuminuria | 2 | 2024 | 181 | 0.090 |
Why?
|
| Self Care | 1 | 2013 | 144 | 0.090 |
Why?
|
| Age Factors | 3 | 2020 | 1261 | 0.090 |
Why?
|
| Stress, Psychological | 2 | 2025 | 233 | 0.090 |
Why?
|
| Models, Biological | 1 | 2014 | 426 | 0.090 |
Why?
|
| Vagina | 1 | 2012 | 61 | 0.090 |
Why?
|
| Neuropsychological Tests | 2 | 2024 | 372 | 0.090 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2011 | 23 | 0.090 |
Why?
|
| Pregnancy Proteins | 1 | 2011 | 14 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2011 | 10 | 0.090 |
Why?
|
| Molar, Third | 1 | 2011 | 2 | 0.090 |
Why?
|
| Tooth Extraction | 1 | 2011 | 18 | 0.090 |
Why?
|
| Cryotherapy | 1 | 2011 | 13 | 0.090 |
Why?
|
| Minocycline | 1 | 2011 | 12 | 0.090 |
Why?
|
| Neoplasms | 1 | 2019 | 791 | 0.090 |
Why?
|
| Pre-Eclampsia | 1 | 2011 | 67 | 0.080 |
Why?
|
| Child, Preschool | 3 | 2021 | 1354 | 0.080 |
Why?
|
| Alabama | 2 | 2021 | 41 | 0.080 |
Why?
|
| Vitamin D | 1 | 2011 | 187 | 0.080 |
Why?
|
| Infant, Newborn | 3 | 2017 | 730 | 0.080 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2013 | 364 | 0.080 |
Why?
|
| Research Design | 2 | 2025 | 337 | 0.080 |
Why?
|
| Pain, Postoperative | 1 | 2011 | 205 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 352 | 0.070 |
Why?
|
| Forensic Toxicology | 2 | 2020 | 3 | 0.070 |
Why?
|
| Blood Pressure | 2 | 2024 | 901 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2021 | 565 | 0.060 |
Why?
|
| Logistic Models | 2 | 2021 | 808 | 0.060 |
Why?
|
| Dental Caries Susceptibility | 2 | 2017 | 2 | 0.060 |
Why?
|
| Educational Status | 2 | 2018 | 185 | 0.060 |
Why?
|
| Predictive Value of Tests | 3 | 2013 | 934 | 0.060 |
Why?
|
| Freezing | 1 | 2025 | 7 | 0.060 |
Why?
|
| Infant | 2 | 2019 | 1122 | 0.060 |
Why?
|
| Secondary Prevention | 1 | 2025 | 74 | 0.050 |
Why?
|
| Glasgow Outcome Scale | 1 | 2024 | 3 | 0.050 |
Why?
|
| Cryopreservation | 1 | 2025 | 55 | 0.050 |
Why?
|
| Calcium Channel Blockers | 1 | 2024 | 54 | 0.050 |
Why?
|
| Patient-Centered Care | 1 | 2025 | 77 | 0.050 |
Why?
|
| Executive Function | 1 | 2024 | 60 | 0.050 |
Why?
|
| Health Surveys | 1 | 2024 | 202 | 0.050 |
Why?
|
| Snoring | 1 | 2024 | 10 | 0.050 |
Why?
|
| Patient Care Team | 1 | 2025 | 130 | 0.050 |
Why?
|
| Transportation | 1 | 2023 | 13 | 0.050 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2024 | 138 | 0.050 |
Why?
|
| Population Dynamics | 1 | 2023 | 6 | 0.050 |
Why?
|
| Social Environment | 1 | 2023 | 82 | 0.050 |
Why?
|
| Cardiovascular System | 1 | 2023 | 51 | 0.050 |
Why?
|
| Cholinergic Antagonists | 1 | 2023 | 10 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2024 | 257 | 0.050 |
Why?
|
| Ambulatory Care Facilities | 1 | 2023 | 87 | 0.050 |
Why?
|
| Monte Carlo Method | 1 | 2022 | 25 | 0.050 |
Why?
|
| Censuses | 1 | 2022 | 10 | 0.050 |
Why?
|
| Pseudouridine | 1 | 2022 | 1 | 0.050 |
Why?
|
| Guanosine | 1 | 2022 | 2 | 0.050 |
Why?
|
| Neurotensin | 1 | 2022 | 4 | 0.050 |
Why?
|
| Nucleosides | 1 | 2022 | 10 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2022 | 85 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2022 | 142 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 2366 | 0.040 |
Why?
|
| Cities | 1 | 2021 | 8 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 1 | 2023 | 315 | 0.040 |
Why?
|
| Particulate Matter | 1 | 2021 | 32 | 0.040 |
Why?
|
| Glucose | 1 | 2022 | 194 | 0.040 |
Why?
|
| Food Supply | 1 | 2022 | 68 | 0.040 |
Why?
|
| Hemoglobin, Sickle | 1 | 2021 | 9 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2022 | 109 | 0.040 |
Why?
|
| Income | 1 | 2021 | 68 | 0.040 |
Why?
|
| Child Behavior | 1 | 2021 | 27 | 0.040 |
Why?
|
| Environmental Exposure | 1 | 2021 | 91 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2022 | 146 | 0.040 |
Why?
|
| Movement | 1 | 2021 | 62 | 0.040 |
Why?
|
| Pain Threshold | 1 | 2021 | 105 | 0.040 |
Why?
|
| Coroners and Medical Examiners | 1 | 2020 | 6 | 0.040 |
Why?
|
| Lumbar Vertebrae | 1 | 2021 | 113 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2021 | 323 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2020 | 100 | 0.040 |
Why?
|
| Video Recording | 1 | 2020 | 64 | 0.040 |
Why?
|
| Life Style | 1 | 2022 | 418 | 0.040 |
Why?
|
| Parenting | 1 | 2020 | 24 | 0.040 |
Why?
|
| Lung Diseases | 1 | 2020 | 51 | 0.040 |
Why?
|
| Genome-Wide Association Study | 1 | 2022 | 555 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2020 | 194 | 0.040 |
Why?
|
| Age Distribution | 1 | 2020 | 211 | 0.040 |
Why?
|
| Disability Evaluation | 1 | 2020 | 262 | 0.040 |
Why?
|
| Central Nervous System Stimulants | 1 | 2020 | 85 | 0.040 |
Why?
|
| Physicians, Family | 1 | 2019 | 16 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2023 | 502 | 0.040 |
Why?
|
| Linear Models | 1 | 2020 | 464 | 0.040 |
Why?
|
| Republic of Korea | 1 | 2018 | 12 | 0.040 |
Why?
|
| Japan | 1 | 2018 | 20 | 0.040 |
Why?
|
| Lipids | 1 | 2020 | 267 | 0.040 |
Why?
|
| Waist Circumference | 1 | 2018 | 94 | 0.040 |
Why?
|
| American Heart Association | 1 | 2019 | 92 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2019 | 143 | 0.040 |
Why?
|
| Meconium | 1 | 2017 | 2 | 0.030 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2017 | 8 | 0.030 |
Why?
|
| Cause of Death | 1 | 2019 | 245 | 0.030 |
Why?
|
| Opiate Alkaloids | 1 | 2017 | 2 | 0.030 |
Why?
|
| Biological Assay | 1 | 2017 | 19 | 0.030 |
Why?
|
| Cardiology | 1 | 2019 | 110 | 0.030 |
Why?
|
| Dentifrices | 1 | 2017 | 1 | 0.030 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2017 | 95 | 0.030 |
Why?
|
| Random Allocation | 1 | 2017 | 257 | 0.030 |
Why?
|
| Mortality | 1 | 2017 | 127 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 612 | 0.030 |
Why?
|
| Hallucinogens | 1 | 2016 | 12 | 0.030 |
Why?
|
| Mouthwashes | 1 | 2015 | 3 | 0.030 |
Why?
|
| Fluorides, Topical | 1 | 2015 | 6 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 2018 | 260 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 429 | 0.030 |
Why?
|
| Gestational Age | 1 | 2016 | 134 | 0.030 |
Why?
|
| Learning | 1 | 2016 | 88 | 0.030 |
Why?
|
| Aging | 1 | 2022 | 1010 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 304 | 0.030 |
Why?
|
| Powders | 1 | 2014 | 9 | 0.030 |
Why?
|
| Tooth, Deciduous | 1 | 2014 | 3 | 0.030 |
Why?
|
| Particle Size | 1 | 2014 | 49 | 0.030 |
Why?
|
| Rheology | 1 | 2014 | 35 | 0.030 |
Why?
|
| Urban Health | 1 | 2014 | 15 | 0.030 |
Why?
|
| Dental Care | 1 | 2014 | 18 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2014 | 106 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2014 | 107 | 0.030 |
Why?
|
| Length of Stay | 1 | 2016 | 335 | 0.030 |
Why?
|
| Birth Weight | 1 | 2014 | 51 | 0.030 |
Why?
|
| Materials Testing | 1 | 2014 | 93 | 0.030 |
Why?
|
| Mexican Americans | 1 | 2014 | 63 | 0.030 |
Why?
|
| Breast Feeding | 1 | 2014 | 47 | 0.030 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2014 | 44 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2015 | 378 | 0.030 |
Why?
|
| Poverty | 1 | 2014 | 118 | 0.030 |
Why?
|
| Fertilization | 1 | 2013 | 5 | 0.030 |
Why?
|
| Nutrition Surveys | 1 | 2014 | 156 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 259 | 0.020 |
Why?
|
| Attitude to Health | 1 | 2014 | 161 | 0.020 |
Why?
|
| Nonlinear Dynamics | 1 | 2012 | 77 | 0.020 |
Why?
|
| Atherosclerosis | 1 | 2019 | 837 | 0.020 |
Why?
|
| Administration, Intravaginal | 1 | 2012 | 9 | 0.020 |
Why?
|
| Pregnancy Rate | 1 | 2012 | 11 | 0.020 |
Why?
|
| Creatinine | 1 | 2012 | 206 | 0.020 |
Why?
|
| Mandible | 1 | 2011 | 39 | 0.020 |
Why?
|
| ROC Curve | 1 | 2011 | 176 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2011 | 99 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2011 | 118 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 703 | 0.020 |
Why?
|
| Administration, Topical | 1 | 2011 | 146 | 0.020 |
Why?
|
| Osteotomy | 1 | 2011 | 57 | 0.020 |
Why?
|
| Analgesics | 1 | 2011 | 117 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2011 | 589 | 0.020 |
Why?
|
| North Carolina | 1 | 2012 | 1612 | 0.020 |
Why?
|